Table 2.
Newcastle-Ottawa score6 for the cohort studies included in the systematic review
| Study | Representativeness of participants | Selection of nonexposed cohort | Ascertainment of exposure | Outcome not present | Comparability of controls | Assessment of outcome | Adequate follow-up | Loss to follow-up | Total score |
|---|---|---|---|---|---|---|---|---|---|
| Kluger et al.8 | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
| Jacobs et al.9 | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
| Jacobs et al.10 | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
| Gaarder et al.11 | Truly representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
| King et al.13 | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
| Tugnoli et al.14 | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
| Sohn et al.15 | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
| Sohn et al.16 | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
| Rubiano et al.17 | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
| McLaughlin et al.19 | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
Refer to Wells et al.6 for a description of Newcastle–Ottawa Quality Assessment Scale for cohort studies. In general, more stars denote higher quality. Representativeness is awarded a star if the cohort is truly or somewhat representative of the population of interest. For selection of the nonexposed cohort, a star is awarded if it is drawn from the same population as the exposed cohort. The relevant exposure in this review is the surgical procedure performed in the live tissue; we considered a nonexposed cohort to be one that performed the procedure in another simulation method. Exposure is satisfactorily ascertained if data are collected from a secure record. A star is awarded if the outcome is not present at the start of the study. A maximum of 2 stars can be given for comparability of controls for controlling of confounders in either the design (matching) or analysis (statistical adjustment) phase. We also gave 1 star when selection criteria appeared to create comparable groups via restriction. Assessment of outcome is awarded a star if the outcomes were assessed by independent blind assessment or record linkage. The duration of follow-up was considered adequate if it was long enough for the outcomes to occur. Completeness of follow-up was considered adequate if all participants were accounted for or if the number lost to follow-up was sufficiently low to be unlikely to introduce bias.